| Literature DB >> 22952620 |
Ebba Abate1, Meseret Belayneh, Aschalew Gelaw, Jonna Idh, Assefa Getachew, Shitaye Alemu, Ermias Diro, Nigussu Fikre, Sven Britton, Daniel Elias, Abraham Aseffa, Olle Stendahl, Thomas Schön.
Abstract
BACKGROUND: Areas endemic of helminth infection, tuberculosis (TB) and HIV are to a large extent overlapping. The aim of this study was to assess the impact of asymptomatic helminth infection on the immunological response among TB patients with and without HIV, their house hold contacts and community controls.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22952620 PMCID: PMC3430660 DOI: 10.1371/journal.pone.0042901
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Comparison of immunological characteristics among participants in TB patients, community controls and house hold contacts.
| Variables | TB (n = 112) | CC (n = 112) | HC (n = 71) | p-value |
| Gender (Median age) : M | 53 (28) | 101(30) | 27(17) | |
| F | 59(27) | 11(25) | 44(25) | |
| Median HIV positive; n (%) | 53 (47%) | 2 (1.8%) | 8/69 (11.6%) | <0.001 |
| Median CD4 in HIV negative (iqr) | 513 (390–682) | 750(627–923) | 714 (578–825) | 0.32 |
| Median eosinophil of helminth positive (iqr) | 234 (116–424) | 600 (492–960) | 602 (270–850) | <0.001 |
| Median IgE of Helminth positive (iqr) | 351 (145.5–913) | 378 (188–507) | 420 (127–760) | <0.001 |
Significant differences between groups are depicted with their respective p-values.
TB patients compared with CCs (community contros);
TB patients compare with HCs (household contacts).
Intestinal helminths identified among study participants included in TB patients, community controls and house hold contacts.
|
| Groups | ||
| TB (n = 32) | CCs (n = 23) | HCs (n = 15) | |
| n (%) | n (%) | n (%) | |
|
| 12 (38) | 14 (61) | 5 (33) |
|
| 8 (25) | 12 (52) | 5 (33) |
|
| 6 (19) | 3 (13) | 3 (20) |
|
| 8 (25) | 1 (4) | 1 (7) |
|
| 3 (9) | 0 | 0 |
|
| 0 | 1 (4) | 0 |
|
| 0 | 0 | 1 (7) |
Immunological characteristics with respect to helminth status among participants in the TB, community control and household contact groups.
| TB (n = 112) | CCs (n = 112) | HHCs (n = 71) | |||||||
| Helminth positive | Helminth negative | p-value | Helminth positive | Helminth negative | p-value | Helminth positive | Helminth negative | p-value | |
| n = 32 | n = 80 | n = 23 | n = 89 | n = 15 | n = 56 | ||||
| HIV positive, (%) | 13 (25) | 19 (68) | 0.25 | 1 (4) | 1 (1) | 0.74 | 1 (7) | 7 (13) | 0.44 |
| CD4, median (iqr) | 310 (120–602) | 314 (144–518) | 0.58 | 650 (592–757) | 781 (645–949) | 0.21 | 653 (605–752) | 714 (554–855) | 0.5 |
| Eosinophilia, | 46% (10/22) | 20% (10/50) |
| 94% (17/18) | 65% (34/52) |
| 69% (9/13) | 48% (10/21) | 0.38 |
| >300 cells/mm3 | |||||||||
| Eosinophilia, | 23% (5/22) | 8% (4/50) | 0.05 | 72% (13/18) | 52% (27/52) | 0.07 | 62% (8/13) | 33% (7/21) | 0.06 |
| >500 cells/mm3 | |||||||||
| Elevated IgE, | 75% (18/24) | 51% (33/65) |
| 94% (17/18) | 62% (32/52) |
| 77% (10/13) | 14% (3/21) |
|
| >120 IU/l | |||||||||
Figure 1Trends of helminth status of HIV positive and HIV negative patients during TB treatment.